07/04/2024 - 09/04/2024, 6:00 am-6:00 pm - Berlin, Germany
The European Heart Rhythm Association (EHRA) Congress will be held on April 7-9, 2024. EHRA is the leading European EP conference and brings together scientists, healthcare professionals and key opinion leaders involved in arrhythmia management from all around the world.
We are pleased to invite you to attend the AtriCure symposium, visit booth B590, and learning lab to explore the latest clinical science and discover novel strategies for the treatment of Atrial Fibrillation with Hybrid AF™ Therapies.
Venue: CityCube Berlin
Messedamm 26, 14055 Berlin, Germany
Click here to get the AtriCure EHRA 2024 Digital Booklet
High-level program:
Symposium: Monday, April 8, 12:30-15:15 in Room 2/Streamed on Channel 2
“Advanced Approaches to Combined Epicardial and Endocardial Strategies – From New Consensus to Practice”
Hear insightful discussions from internationally renowned speakers on how Hybrid AF™ Therapies can be safe and effective for persistent and longstanding persistent AF patients.
Exhibition Booth B590:
Discuss with our experts the latest innovations and clinical data.
Simulation Village – Workshop 6:
Practice hands-on techniques on AtriCure’s innovative simulation model.
Poster Presentation: Monday, April 8, 10:30-11:15, Moderated ePosters 2
“Two-Year Safety and Effectiveness of Hybrid Ablation Versus Catheter Ablation in Patients With Non-Paroxysmal AF: Mid-Term Results of the CEASE-AF Trial”
At EHRA 2024, Dr. Maurits Wijffels will present on April 8 the two-year safety and effectiveness of hybrid ablation versus catheter ablation in patients with non-paroxysmal AF, highlighting the mid-term results of the CEASE-AF trial.
Presenter: Maurits Wijffels, MD – St Antonius Hospital – Nieuwegein, the Netherlands
For more information about EHRA, please visit the website: https://www.escardio.org/Congresses-&-Events/EHRA-Congress
Follow AtriCure of LinkedIn or X (formerly Twitter) to stay updated for more information as we get closer to the event date.